Paul Conlin, MD

Adjunct Professor, Medicine

Paul Conlin
72 E. Concord St Building A

Biography

Dr. Conlin is Chief, Medical Service at VA Boston Healthcare System, Professor of Medicine at Harvard Medical School and Maurice Strauss Chair at Boston University School of Medicine. He is also Director of the Clinical and Translational Research Academy in Harvard Catalyst – The Harvard Clinical and Translational Science Center. Dr. Conlin has been a practicing endocrinologist at VA Boston since 1989 and is Chair, VA Diabetes-Endocrinology Field Advisory Committee. His research focuses on improving patient-centered care for individuals with diabetes mellitus using information technology and health services approaches.

Other Positions

  • VA Boston Healthcare System

Education

  • University of Massachusetts Medical School, MD
  • Boston College, BS

Publications

  • Published on 4/1/2020

    Rosenzweig JL, Conlin PR, Gonzalvo JD, Kutler SB, Maruthur NM, Solis P, Vijan S, Wallia A, Wright RF. 2019 Endocrine Society Measures Set for Older Adults With Type 2 Diabetes Who Are at Risk for Hypoglycemia. J Clin Endocrinol Metab. 2020 Apr 01; 105(4). PMID: 31825487.

    Read at: PubMed
  • Published on 7/31/2019

    Maris SA, Williams JS, Sun B, Brown S, Mitchell GF, Conlin PR. Interactions of the DASH Diet with the Renin-Angiotensin-Aldosterone System. Curr Dev Nutr. 2019 Sep; 3(9):nzz091. PMID: 31528838.

    Read at: PubMed
  • Published on 6/26/2018

    Aron DC, Conlin PR, Pogach L. Brief Commentary: The Glycemic Target Guideline Controversy: Same Evidence, Different Perspectives, and a Proposal for Common Ground. Ann Intern Med. 2018 08 21; 169(4):248-249. PMID: 29946698.

    Read at: PubMed
  • Published on 10/24/2017

    Conlin PR, Colburn J, Aron D, Pries RM, Tschanz MP, Pogach L. Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus. Ann Intern Med. 2017 Nov 07; 167(9):655-663. PMID: 29059687.

    Read at: PubMed
  • Published on 10/1/2017

    Tschanz MP, Watts SA, Colburn JA, Conlin PR, Pogach LM. Overview and Discussion of the 2017 VA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus in Primary Care. Fed Pract. 2017 Oct; 34(Suppl 8):S14-S19. PMID: 30766312.

    Read at: PubMed
  • Published on 8/8/2017

    Kerfoot BP, Gagnon DR, McMahon GT, Orlander JD, Kurgansky KE, Conlin PR. A Team-Based Online Game Improves Blood Glucose Control in Veterans With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2017 Sep; 40(9):1218-1225. PMID: 28790131.

    Read at: PubMed
  • Published on 8/1/2017

    Vimalananda VG, DeSotto K, Chen T, Mullakary J, Schlosser J, Archambeault C, Peck J, Cassidy H, Conlin PR, Evans S, McConnell M, Shirley E. A Quality Improvement Program to Reduce Potential Overtreatment of Diabetes Among Veterans at High Risk of Hypoglycemia. Diabetes Spectr. 2017 Aug; 30(3):211-216. PMID: 28848316.

    Read at: PubMed
  • Published on 7/17/2016

    Prentice JC, Pizer SD, Conlin PR. Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes. Diabet Med. 2016 Dec; 33(12):1640-1648. PMID: 27279250.

    Read at: PubMed
  • Published on 5/20/2015

    Conlin PR, Asefzadeh B, Pasquale LR, Selvin G, Lamkin R, Cavallerano AA. Accuracy of a technology-assisted eye exam in evaluation of referable diabetic retinopathy and concomitant ocular diseases. Br J Ophthalmol. 2015 Dec; 99(12):1622-7. PMID: 25995299.

    Read at: PubMed
  • Published on 3/1/2015

    Prentice JC, Conlin PR, Gellad WF, Edelman D, Lee TA, Pizer SD. Long-term outcomes of analogue insulin compared with NPH for patients with type 2 diabetes mellitus. Am J Manag Care. 2015 Mar 01; 21(3):e235-43. PMID: 26014311.

    Read at: PubMed

View 95 more publications: View full profile at BUMC

View all profiles